Drug Prices
Rosen Law Firm Announces Class Action Lawsuit Against Aardvark Therapeutics Over Drug Safety Disclosures
Law firm Rosen announces securities class action against Aardvark Therapeutics following FDA clinical hold on lead drug candidate ARD-101, with investors facing an October 13, 2026 deadline to seek lead plaintiff status....